Jane Street Group, LLC Myriad Genetics Inc Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 18,168 shares of MYGN stock, worth $194,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,168

Previous 121,181 85.01%

Holding current value

$194,942

Previous $3.32 Million 92.49%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.17 - $27.03 $1.36 Million - $2.78 Million	-103,013 Reduced 85.01%	18,168 $249,000
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $471,825 - $562,962	19,684 Added 19.39%	121,181 $3.32 Million
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $1.2 Million - $1.7 Million	66,711 Added 191.78%	101,497 $2.48 Million
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $492,871 - $660,991	-28,020 Reduced 44.61%	34,786 $741,000
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $295,559 - $453,007	21,248 Added 51.13%	62,806 $1.2 Million
Q3 2023 Nov 14, 2023	SELL	$15.99 - $23.22 $996,704 - $1.45 Million	-62,333 Reduced 60.0%	41,558 $666,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $638,692 - $864,198	36,372 Added 53.87%	103,891 $2.41 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $575,988 - $896,443	37,745 Added 126.77%	67,519 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $133,593 - $193,254	9,207 Added 44.77%	29,774 $432,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $374,525 - $573,407	20,567 New	20,567 $392,000
Q2 2022 Aug 16, 2022	SELL	$16.45 - $25.88 $556,240 - $875,106	-33,814 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$22.67 - $28.01 $288,181 - $356,063	12,712 Added 60.24%	33,814 $852,000
Q4 2021 Feb 15, 2022	SELL	$24.13 - $32.63 $2,364 - $3,197	-98 Reduced 0.46%	21,102 $583,000
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $209,061 - $268,510	8,234 Added 63.5%	21,200 $648,000
Q1 2021 May 18, 2021	SELL	$19.92 - $31.6 $753,334 - $1.2 Million	-37,818 Reduced 74.47%	12,966 $395,000
Q4 2020 Feb 17, 2021	SELL	$12.16 - $19.77 $31,251 - $50,808	-2,570 Reduced 4.82%	50,784 $1.01 Million
Q3 2020 Nov 17, 2020	BUY	$11.25 - $14.75 $132,288 - $173,445	11,759 Added 28.27%	53,354 $696,000
Q2 2020 Aug 17, 2020	BUY	$10.69 - $16.49 $444,650 - $685,901	41,595 New	41,595 $471,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $209,575 - $632,798	-21,429 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $201,325 - $337,626	9,619 Added 81.45%	21,429 $584,000
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $260,764 - $556,014	11,810 New	11,810 $338,000
Q2 2018 Aug 15, 2018	SELL	$27.75 - $40.17 $287,601 - $416,321	-10,364 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $298,794 - $425,027	10,364 New	10,364 $306,000

Others Institutions Holding MYGN

# of Institutions

228

Shares Held

92M

Call Options Held

297K

Put Options Held

20.7K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $865M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Myriad Genetics Inc Transaction History